Company / EPS (Basic)
Boston Scientific EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$1.96
FY2025
5-year range
$0.45 / $3.38
FY2021-FY2025
Trend
+55.6%
vs FY2024
Sector context
#56 of 160
Health Care
What the data says
At $1.96, Boston Scientific's eps (basic) ranks #56 of 160 in the Health Care sector. EPS (Basic) has increased for 3 consecutive years, from $0.45 in FY2022 to $1.96 in FY2025.
Based on SEC 10-K filings.
1.96 in FY2025 with a 5-year CAGR of +10.1%.
Improved from $0.69 to $1.96 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +63.3%
- 5-Year CAGR
- +10.1%
- 10-Year CAGR
- -
Sector benchmark
#56 of 160 in Health CareTop 35% of 160This company $1.96 Sector average $1.57
▼
+24.5% above sector average
Key checks
Key Insights
- Boston Scientific's eps (basic) has grown for 3 consecutive years.
- In FY2025, eps (basic) increased 55.6% year-over-year.
- Ranks #56 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.96 | +55.6% |
| FY2024 | $1.26 | +82.6% |
| FY2023 | $0.69 | +53.3% |
| FY2022 | $0.45 | -86.7% |
| FY2021 | $3.38 | +179.3% |
| FY2020 | $1.21 | -64.2% |
| FY2019 | $3.38 | +179.3% |
| FY2018 | $1.21 | +1412.5% |
| FY2017 | $0.08 | +188.9% |
| FY2016 | -$0.09 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026